Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.

Tranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI (95% confidence interval (CI), 1.20-2.00; p<0.001) after treat-ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94 (95% CI 0.10-1.79; p = 0.03). Side-effects were minor, with a few cases reporting hypo-menorrhoea, mild abdominal discomfort, and transient skin irritation. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.

[1]  M. Timalsina,et al.  Oral tranexamic acid for the treatment of melasma , 2018, Clincal and Experimental Dermatology.

[2]  S. Chua,et al.  Oral tranexamic acid lightens refractory melasma , 2017, The Australasian journal of dermatology.

[3]  T. Thng,et al.  Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. , 2016, Journal of the American Academy of Dermatology.

[4]  J. Lee,et al.  Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study , 2016, The Journal of dermatological treatment.

[5]  R. Fujiwara,et al.  Efficacy and possible mechanisms of topical tranexamic acid in melasma , 2016, Clinical and experimental dermatology.

[6]  T. Padhi,et al.  Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial , 2015, Indian journal of dermatology.

[7]  A. Pandya,et al.  Melasma: clinical diagnosis and management options , 2015, The Australasian journal of dermatology.

[8]  P. Bahadoran,et al.  Copper Bromide Laser vs Triple-Combination Cream for the Treatment of Melasma: A Randomized Clinical Trial. , 2015, JAMA dermatology.

[9]  M. Kumaran,et al.  Glycolic Acid Peels/Azelaic Acid 20% Cream Combination and Low Potency Triple Combination Lead to Similar Reduction in Melasma Severity in Ethnic Skin: Results of a Randomized Controlled Study , 2015, Indian journal of dermatology.

[10]  B. Ebrahimi,et al.  Topical tranexamic acid as a promising treatment for melasma , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[11]  J. Na,et al.  Effect of tranexamic acid on melasma: a clinical trial with histological evaluation , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  L. Budamakuntla,et al.  A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma , 2013, Journal of cutaneous and aesthetic surgery.

[13]  E. Hui,et al.  Tranexamic acid: an important adjuvant in the treatment of melasma , 2013, Journal of cosmetic dermatology.

[14]  A. Manosroi,et al.  Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial , 2012, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[15]  Vaneeta M. Sheth,et al.  Melasma: a comprehensive update: part I. , 2011, Journal of the American Academy of Dermatology.

[16]  P. Bahadoran,et al.  Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. , 2011, Archives of dermatology.

[17]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[18]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[19]  J. Ortonne,et al.  Therapeutical approaches in melasma. , 2007, Dermatologic clinics.

[20]  Eun-So Lee,et al.  The vascular characteristics of melasma. , 2007, Journal of dermatological science.

[21]  Keyvan Nouri,et al.  The treatment of melasma: a review of clinical trials. , 2006, Journal of the American Academy of Dermatology.

[22]  T. Cestari,et al.  Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL‐BP study and improvement of QoL of melasma patients after triple combination therapy , 2006, The British journal of dermatology.

[23]  Mi-Yeon Kim,et al.  Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian Patients: A Preliminary Clinical Trial , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[24]  Sungnack Lee,et al.  Intermittent Therapy for Melasma in Asian Patients with Combined Topical Agents (Retinoic Acid, Hydroquinone and Hydrocortisone): Clinical and Histological Studies , 1998, The Journal of dermatology.

[25]  T. Hamilton,et al.  Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. , 1994, Archives of dermatology.

[26]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.